• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危及生命的出血与原发性系统性淀粉样变性相关的获得性凝血因子V缺乏症。

Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.

作者信息

Emori Y, Sakugawa M, Niiya K, Kiguchi T, Kojima K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Tanimoto M, Yamasaki R, Ohara N, Harada M

机构信息

Second Department of Medicine, Okayama University Medical School, Japan.

出版信息

Blood Coagul Fibrinolysis. 2002 Sep;13(6):555-9. doi: 10.1097/00001721-200209000-00011.

DOI:10.1097/00001721-200209000-00011
PMID:12192308
Abstract

Acquired factor X deficiency has been described in patients with amyloidosis but acquired factor V deficiency is quite rare. We report here a case of life-threatening bleeding and acquired factor V deficiency associated with primary amyloidosis. A 50-year-old man who had no previous hemorrhagic diathesis was referred to our hospital because of recurrent epistaxis, gingival bleeding and hemospermia. The laboratory examination revealed that both the prothrombin time (PT) and the activated partial thromboplastin time (aPTT) were significantly prolonged, and factor V activities were markedly decreased to 14-39% of the normal value. Other coagulation factors such as fibrinogen, prothrombin, factor VII, factor VIII, factor IX and factor X were subnormal and normal. Transaminases were slightly elevated but serological tests of hepatitis B and hepatitis C were negative. Mild hepatosplenomegaly was noted without sign of liver cirrhosis. The PT and aPTT obtained 8 years ago when he received a cholecystectomy due to cholecystitis were both normal. Specific assays for the detection of factor V inhibitor were repeatedly performed but no factor V inhibitor was found. Furthermore, a significant recovery of the infused factor V was noted shortly after an intravenous administration of 5-10 U fresh frozen plasma, but it did not last more than 6 h. Melena, bleedings into the left shoulder and buttock, and finally mortal retroperitoneal hemorrhage developed despite repeated infusions of large amounts of fresh frozen plasma. Acquired factor V deficiency associated with primary amyloidosis was suspected but histological diagnosis was not obtained because of the severe bleeding tendency. Autopsy revealed hepatosplenomegaly and massive deposits of AL amyloid in the liver, spleen, heart and other parenchymal organs. Perivascular amyloid deposition and factor V deficiency are both thought to be the cause of the severe hemorrhagic tendency seen in this patient.

摘要

获得性因子X缺乏症在淀粉样变性患者中已有报道,但获得性因子V缺乏症相当罕见。我们在此报告一例与原发性淀粉样变性相关的危及生命的出血和获得性因子V缺乏症病例。一名既往无出血素质的50岁男性因反复鼻出血、牙龈出血和血精症被转诊至我院。实验室检查显示,凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)均显著延长,因子V活性明显降低至正常值的14% - 39%。其他凝血因子如纤维蛋白原、凝血酶原、因子VII、因子VIII、因子IX和因子X均低于正常或正常。转氨酶轻度升高,但乙肝和丙肝血清学检测均为阴性。发现轻度肝脾肿大,但无肝硬化迹象。8年前他因胆囊炎接受胆囊切除术时测得的PT和aPTT均正常。多次进行检测因子V抑制剂的特异性试验,但未发现因子V抑制剂。此外,静脉输注5 - 10 U新鲜冰冻血浆后不久,输注的因子V有显著恢复,但持续时间不超过6小时。尽管反复输注大量新鲜冰冻血浆,仍出现黑便、左肩和臀部出血,最终发生致命的腹膜后出血。怀疑与原发性淀粉样变性相关的获得性因子V缺乏症,但由于严重的出血倾向未获得组织学诊断。尸检显示肝脾肿大,肝脏、脾脏、心脏和其他实质器官有大量AL淀粉样蛋白沉积。血管周围淀粉样蛋白沉积和因子V缺乏均被认为是该患者出现严重出血倾向的原因。

相似文献

1
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.危及生命的出血与原发性系统性淀粉样变性相关的获得性凝血因子V缺乏症。
Blood Coagul Fibrinolysis. 2002 Sep;13(6):555-9. doi: 10.1097/00001721-200209000-00011.
2
[AL amyloidosis-associated factor X deficiency].[AL淀粉样变性相关因子X缺乏症]
Ned Tijdschr Geneeskd. 2014;158(6):A6678.
3
Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.血管性血友病因子沉积和因子V沉积于AL淀粉样蛋白上作为严重出血素质病因的证据。
Blood Coagul Fibrinolysis. 2017 Jun;28(4):342-347. doi: 10.1097/MBC.0000000000000600.
4
Acquired factor V deficiency in a patient with myeloma and amyloidosis.骨髓瘤伴淀粉样变性患者获得性因子 V 缺乏症。
Thromb Res. 2018 Apr;164:1-3. doi: 10.1016/j.thromres.2018.01.045. Epub 2018 Jan 31.
5
A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.凝血酶原时间与 Normotest(Hepaplastin 试验)结果之间的差异对于获得性因子 V 抑制剂的诊断很有用。
Int J Hematol. 2018 Aug;108(2):145-150. doi: 10.1007/s12185-018-2453-z. Epub 2018 Apr 2.
6
Factor V Deficiency因子V缺乏症
7
Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.轻链淀粉样变性中的获得性因子X缺乏症:2例韩国病例报告。
Korean J Lab Med. 2011 Jul;31(3):154-6. doi: 10.3343/kjlm.2011.31.3.154. Epub 2011 Jun 28.
8
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.获得性因子VII缺乏导致继发于肝脏AL淀粉样变性的严重出血性疾病。
Hematol Rep. 2018 Sep 24;10(3):7235. doi: 10.4081/hr.2018.7235. eCollection 2018 Sep 5.
9
A case of factor V inhibitor.一例凝血因子V抑制剂病例。
Am J Hematol. 1985 Aug;19(4):395-9. doi: 10.1002/ajh.2830190410.
10
[Recurrent spontaneous hemorrhage in a patient with light chain immunocytoma].[轻链免疫细胞瘤患者复发性自发性出血]
Praxis (Bern 1994). 2002 Jan 23;91(4):112-8. doi: 10.1024/0369-8394.91.4.112.

引用本文的文献

1
Viruses and amyloids - a vicious liaison.病毒与淀粉样纤维——一种恶性关联。
Prion. 2023 Dec;17(1):82-104. doi: 10.1080/19336896.2023.2194212.
2
[Primary light chain amyloidosis onset with acquired FX deficiency: a case report and literature review].[原发性轻链淀粉样变性伴获得性FX缺乏症发病:一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):680-682. doi: 10.3760/cma.j.issn.0253-2727.2020.08.012.
3
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.获得性因子VII缺乏导致继发于肝脏AL淀粉样变性的严重出血性疾病。
Hematol Rep. 2018 Sep 24;10(3):7235. doi: 10.4081/hr.2018.7235. eCollection 2018 Sep 5.
4
Hematospermia-a Symptom With Many Possible Causes.血精症——一种可能病因众多的症状。
Dtsch Arztebl Int. 2017 Mar 17;114(11):186-191. doi: 10.3238/arztebl.2017.0186.
5
Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.头孢他啶治疗后获得性因子V抑制剂的发生:一例病例报告及文献复习
Drug Des Devel Ther. 2015 Apr 24;9:2395-8. doi: 10.2147/DDDT.S68682. eCollection 2015.
6
Acquired factor V deficiency in a patient without evidence of a classical inhibitor.一名无典型抑制剂证据患者的获得性凝血因子V缺乏症
Haemophilia. 2014 Jan;20(1):e81-3. doi: 10.1111/hae.12280. Epub 2013 Oct 14.
7
Acquired factor V inhibitors: a systematic review.获得性因子 V 抑制剂:系统评价。
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
8
Amyloid in surgical pathology.外科病理学中的淀粉样蛋白
Virchows Arch. 2003 Jul;443(1):3-16. doi: 10.1007/s00428-003-0834-y. Epub 2003 Jun 11.